Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionPrudential Financial Inc
Latest Disclosed Ownership550,331 shares
Latest Disclosed Value $ 193,633,963
Prudential Financial Inc reports 16.99% decrease in ownership of AMGN / Amgen Inc.

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 550,331 shares of Amgen Inc. (MX:AMGN) valued at $193,633,963 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 662,952 shares of Amgen Inc.. This represents a change in shares of -16.99% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F AMGEN COM 031162100 550,331 -112,621 -16.99 193,634 -10.76 0.1340
2026-02-13 2025-12-31 13F AMGEN COM 031162100 662,952 -12,694 -1.88 216,991 13.81 0.2620
2025-11-13 2025-09-30 13F AMGEN COM 031162100 675,646 -67,785 -9.12 190,667 -8.14 0.2266
2025-08-12 2025-06-30 13F AMGEN COM 031162100 743,431 21,561 2.99 207,573 -7.70 0.2682
2025-05-13 2025-03-31 13F AMGEN COM 031162100 721,870 106,091 17.23 224,899 40.13 0.3204
2025-02-11 2024-12-31 13F AMGEN COM 031162100 615,779 -29,757 -4.61 160,497 -22.84 0.2200
2024-11-14 2024-09-30 13F AMGEN COM 031162100 645,536 10,238 1.61 207,998 4.79 0.2930
2024-08-13 2024-06-30 13F AMGEN COM 031162100 635,298 115,952 22.33 198,499 34.43 0.2980
2024-05-14 2024-03-31 13F AMGEN COM 031162100 519,346 -6,024 -1.15 147,660 -1.26 0.2079
2024-02-13 2023-12-31 13F AMGEN COM 031162100 525,370 -349,302 -39.94 149,545 -36.38 0.2259
2023-11-13 2023-09-30 13F AMGEN COM 031162100 874,672 167,009 23.60 235,077 49.62 0.3689
2023-08-11 2023-06-30 13F AMGEN COM 031162100 707,663 66,988 10.46 157,115 0.30 0.2288
2023-05-12 2023-03-31 13F AMGEN COM 031162100 640,675 69,020 12.07 156,643 4.33 0.2453
2023-02-14 2022-12-31 13F AMGEN COM 031162100 571,655 -6,604 -1.14 150,140 14.14 0.2530
2022-11-04 2022-09-30 13F AMGEN COM 031162100 578,259 90,579 18.57 131,540 10.23 0.2230
2022-08-15 2022-06-30 13F AMGEN COM 031162100 487,680 -27,387 -5.32 119,330 -4.19 0.1893
2022-05-13 2022-03-31 13F AMGEN COM 031162100 515,067 -50,501 -8.93 124,553 0.92 0.1655
2022-02-14 2021-12-31 13F AMGEN COM 031162100 565,568 2,414 0.43 123,417 0.96 0.1533
2021-11-15 2021-09-30 13F AMGEN COM 031162100 563,154 57,259 11.32 122,245 -0.87 0.1706
2021-08-16 2021-06-30 13F AMGEN COM 031162100 505,895 -61,812 -10.89 123,312 -12.70 0.1697
2021-05-12 2021-03-31 13F AMGEN COM 031162100 567,707 76,486 15.57 141,251 25.07 0.2116
2021-08-16 2020-12-31 13F/A-1 AMGEN COM 0229 031162100 491,221 481,187 4,795.57 112,942 4,329.10 0.1899
2021-02-16 2020-12-31 13F AMGEN COM 031162100 491,221 481,187 112,942 0.1899
2021-08-05 2020-09-30 13F/A-1 AMGEN COM 031162100 10,034 2,381 31.11 2,550 41.27 0.3685
2020-11-16 2020-09-30 13F AMGEN COM 031162100 493,642 485,989 125,464 0.2367
2021-08-05 2020-06-30 13F/A-1 AMGEN COM 0235 031162100 7,653 2,493 48.31 1,805 72.56 0.3342
2020-08-12 2020-06-30 13F AMGEN COM 031162100 796,947 791,787 187,968 0.3619
2021-08-05 2020-03-31 13F/A-1 AMGEN COM 0202 031162100 5,160 1,721 50.04 1,046 26.18 0.2716
2020-05-12 2020-03-31 13F AMGEN COM 031162100 698,982 695,543 141,705 0.3139
2021-08-05 2019-12-31 13F/A-1 AMGEN COM 0241 031162100 3,439 611 21.61 829 51.55 0.2161
2020-02-11 2019-12-31 13F AMGEN COM 031162100 787,746 784,918 189,902 0.2814
2021-08-05 2019-09-30 13F/A-1 AMGEN COM 0193 031162100 2,828 417 17.30 547 23.20 0.1786
2019-11-13 2019-09-30 13F AMGEN COM 031162100 938,768 936,357 181,661 0.2882
2021-08-05 2019-06-30 13F/A-1 AMGEN COM 031162100 2,411 173 7.73 444 4.47 0.1542
2019-08-08 2019-06-30 13F AMGEN COM 031162100 779,562 777,324 143,658 0.2238
2021-08-05 2019-03-31 13F/A-1 AMGEN COM 031162100 2,238 1,114 99.11 425 94.06 0.1804
2019-05-15 2019-03-31 13F AMGEN COM 031162100 803,132 802,008 152,579 0.2541
2021-08-05 2018-12-31 13F/A-1 AMGEN COM 031162100 1,124 663 143.82 219 128.13 0.1774
2019-02-07 2018-12-31 13F AMGEN COM 031162100 949,833 -25,924 184,903 0.3248
2021-09-01 2018-09-30 13F/A-1 AMGEN COM 0207 031162100 461 379 462.20 96 540.00 0.1544
2018-11-07 2018-09-30 13F AMGEN COM 031162100 975,757 975,675 202,265 0.2979
2021-09-01 2018-06-30 13F/A-1 AMGEN COM 031162100 82 -1,555,272 -99.99 15 -99.99 0.0538
2018-08-13 2018-06-30 13F AMGEN COM 031162100 1,394,659 -160,695 257,440 0.3848
2018-05-04 2018-03-31 13F AMGEN COM 031162100 1,555,354 -305,343 -16.41 265,157 -18.05 0.4040
2018-02-13 2017-12-31 13F AMGEN COM 031162100 1,860,697 94,085 5.33 323,575 -1.76 0.4407
2017-11-30 2017-09-30 13F/A-1 AMGEN COM 031162100 1,766,612 122,660 7.46 329,384 16.33 3.5952
2017-08-07 2017-06-30 13F AMGEN COM 031162100 1,643,952 -374,312 -18.55 283,138 -14.50 0.4212
2017-05-10 2017-03-31 13F AMGEN COM 031162100 2,018,264 -244,262 -10.80 331,137 0.10 0.5164
2017-02-07 2016-12-31 13F AMGEN COM 031162100 2,262,526 4,466 0.20 330,804 -12.18 0.5320
2016-11-04 2016-09-30 13F AMGEN COM 031162100 2,258,060 7,060 0.31 376,667 9.98 0.6221
2016-08-09 2016-06-30 13F AMGEN COM 031162100 2,251,000 103,083 4.80 342,490 6.35 0.5761
2016-05-09 2016-03-31 13F AMGEN COM 031162100 2,147,917 21,080 0.99 322,037 -6.72 0.5760
2016-02-12 2015-12-31 13F AMGEN COM 031162100 2,126,837 107,390 5.32 345,249 23.60 0.6251
2015-11-10 2015-09-30 13F AMGEN COM 031162100 2,019,447 -12,060 -0.59 279,330 -10.44 0.5510
2015-08-06 2015-06-30 13F AMGEN COM 031162100 2,031,507 5,400 0.27 311,877 -3.70 0.5537
2015-05-01 2015-03-31 13F AMGEN COM 031162100 2,026,107 308,930 17.99 323,874 18.41 0.5613
2015-02-06 2014-12-31 13F AMGEN COM 031162100 1,717,177 -123,140 -6.69 273,529 5.82 0.4959
2014-11-12 2014-09-30 13F AMGEN COM 031162100 1,840,317 -222,422 -10.78 258,491 5.87 0.4865
2014-08-13 2014-06-30 13F AMGEN COM 031162100 2,062,739 53,031 2.64 244,166 -1.50 0.4307
2014-05-14 2014-03-31 13F AMGEN COM 031162100 2,009,708 99,734 5.22 247,878 13.68 0.4614
2014-02-11 2013-12-31 13F AMGEN COM 031162100 1,909,974 -182,010 -8.70 218,043 -6.89 0.4328
2013-11-07 2013-09-30 13F AMGEN COM 031162100 2,091,984 -242,392 -10.38 234,176 1.68 0.4978
2013-08-07 2013-06-30 13F AMGEN COM 031162100 2,334,376 2,334,376 230,310 0.5104
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.